Intercept Pharma Danmark ApS: Financial statements 2019
CVR: 37104469
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Intercept Pharma Danmark ApS (CVR 37104469) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,803,867 and a net result of DKK -27,225 compared with DKK -7,148,070 the year before. That is an increase of 166.4% compared with the year before. Equity in the 2019 report amounted to DKK -38,893,973. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,803,867
- Profit/Loss
- DKK -27,225
- Equity
- DKK -38,893,973
- Total Assets
- DKK 9,720,561
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 2.8 mio. | -27 t. | -38.9 mio. | 1 |
| 2018 | - | 1.1 mio. | -7.1 mio. | -38.9 mio. | 5 |
| 2017 | - | -9.2 mio. | -25.8 mio. | -31.7 mio. | 5 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Intercept Pharma Danmark ApS has published its annual report for 2018. Gross profit came to DKK 1,052,615, and the net result was DKK -7,148,070.
About Intercept Pharma Danmark ApS
Intercept Pharma Danmark ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company has been dissolved on 2 September 2020. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 1 employee (2018). In 2019, the company reported a gross profit of DKK 2,803,867 and a net result of DKK -27,225 compared with DKK -7,148,070 the year before. Equity in the 2019 report amounted to DKK -38,893,973.